The Substance Abuse and Mental Health Services Administration seeks comments through 5 p.m. Aug. 14 on its draft framework to integrate harm reduction strategies across its initiatives and partnerships for people who use drugs. According to the agency, harm reduction is an evidence-based approach that emphasizes engaging directly with people who use drugs to prevent overdose and infectious disease transmission; improve physical, mental and social well-being; and offer low barrier options for accessing health care services, including substance use and mental health disorder treatment.

Related News Articles

Headline
Corey Feist, CEO and co-founder of the Dr. Lorna Breen Heroes Foundation, and Tiffany Lyttle, R.N., director of cultural integration at Centra Health, discuss…
Blog
Public
Medical residency is one of the most demanding stages in a physician’s career. Long hours, intense learning and new responsibilities often push trainees to…
Headline
A Gallup report published Sept. 9 found that nearly 48 million Americans currently have or are being treated for depression. The total, which equals 18.3% of…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Blog
In this insightful conversation hosted by Nancy Myers of the American Hospital Association, we explore how Owensboro Health (Ky.) and CredibleMind are…